Research InterestsUmut A. Gurkan is leading the CASE Biomanufacturing and Microfabrication Laboratory (CASE-BML). Inspired by modern advanced manufacturing methods, the primary focus of CASE-BML is to develop micro/nano-scale technologies and biomanufacturing complex multiscale biological systems for blood disease research, cardiovascular medicine, orthopaedics, and musculoskeletal health.
Teaching InterestsMicro-Electro-Mechanical Systems in Biology and Medicine (BioMEMS)<br>Mechanics of Biological Fluids<br>Design of Mechanical Elements
Affiliated Department Research Areas
News About Umut Gurkan
Umut Gurkan, Wilbert J. Austin Professor of Engineering, has been re-elected for the National Academies of Sciences, Engineering, and Medicine’s New Voices in Sciences, Engineering, and Medicine program. Gurkan, one of five members from the previous cohort who is extending his service by one year, will join the 2024 cohort.
Of the many traits that unite members of the Case Western Reserve University community, one is perhaps the most inspiring: an innovative spirit.
A private company’s effort to bring its portable point-of-care test for sickle cell disease (SCD) and other inherited blood diseases to the United States is supported by technology developed at Case Western Reserve University.
September is National Sickle Cell Awareness Month, which aims to bring attention to advancing research, care practices, treatments and possible cures for people with sickle cell disease. To better understand this blood disorder, The Daily sat down with Umut Gurkan, a professor in the Department of Mechanical and Aerospace Engineering and member of the Cancer Prevention Control and Population Research program at the Case Comprehensive Cancer Center.
Case Western Reserve University researcher, company, collaborating to develop blood test measuring the effects, potency of new gene therapies for sickle cell disease
Umut Gurkan In the News
Case Western Reserve University has received significant funding from the National Heart, Lung and Blood Institute to support work toward a potential cure for sickle cell disease.